Jolt Health Inc.
JTHTF
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -34.60% | 75.85% | 72.63% | 171.11% | 124.94% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -34.60% | 75.85% | 72.63% | 171.11% | 124.94% |
| Operating Income | 34.60% | -75.85% | -72.63% | -171.11% | -124.94% |
| Income Before Tax | 56.43% | -25.82% | -33.12% | -67.82% | -49.52% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 56.43% | -25.82% | -33.12% | -67.82% | -49.52% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 56.43% | -25.82% | -33.12% | -67.82% | -49.52% |
| EBIT | 34.60% | -75.85% | -72.63% | -171.11% | -124.94% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 68.74% | 11.95% | 9.46% | 7.31% | 22.21% |
| Normalized Basic EPS | 54.61% | -45.19% | -42.23% | -33.89% | 4.47% |
| EPS Diluted | 68.74% | 11.95% | 9.46% | 7.31% | 22.21% |
| Normalized Diluted EPS | 54.61% | -45.19% | -42.23% | -33.89% | 4.47% |
| Average Basic Shares Outstanding | 46.23% | 32.83% | 47.48% | 87.57% | 90.34% |
| Average Diluted Shares Outstanding | 46.23% | 32.83% | 47.48% | 87.57% | 90.34% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |